Mikkilineni et al., in a retrospective analysis of 162 children and adults with a variety of malignancies treated with CAR T-cells directed against a variety of targets (CD19, CD22, GD2, BCMA), also identified those with multiple myeloma as the group with the highest risk for infection (15). This evidence concerns the gene CD19 and infection.